Narayana Hrudayalaya Ltd. has informed the Exchange about Transcript of the Earnings Call of the Company held on Monday, August 04, 2025
NH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Narayana Hrudayalaya filed the transcript of its Q1 FY26 earnings call covering the quarter ended June 30, 2025. Key takeaways include: (1) Cayman operations saw expected early-stage volatility post the new hospital commission, with IP/OP volumes declining sequentially — management termed this as normal ramp-up blips, not structural; (2) Cayman Integrated Care (CIHL) posted an INR 9.3 crore loss in Q1 FY26, diluting consolidated Cayman EBITDA margins, though the core hospital business economics remain unchanged; (3) India businesses — insurance (Aditi, Arya, Aditi Plus) covering ~6,000 lives, and clinic business in Bangalore — continue to ramp up, with total committed investment of INR 450 crores (INR 100 cr capital + INR 150 cr clinics/burn already deployed); (4) ARPP growth was driven by low-single-digit price hike, payor mix improvement, Bangladesh revenue drop substituted by domestic 12% growth, and high-end procedures; (5) ALOS reduced from 4.5 to 4.3, targeting 4.0; (6) New hospital commissions in FY27/FY28 (400-bed pipeline) will cause margin dilution, though absolute EBITDA will grow; (7) Oncology is targeted to reach 20-25% of revenue over 5 years.
Near-term margin pressure is acknowledged from new hospital commissions and Integrated Care losses, which may weigh on the stock in the short term. However, management signalled confidence in absolute earnings growth, a long growth runway, and improving operational efficiency, which supports the longer-term investment case.